| A Study of VERVE-101 in Patients With Familial Hypercholesterolemia and Cardiovascular Disease (NCT05398029) | Verve Therapeutics, Inc. | 2022-07-05 |
| Atherosclerotic Cardiovascular Risk in Childhood and Teen-age Onset Diabetes (NCT05294653) | Shanghai Jiao Tong University School of Medicine | 2022-06-01 |
| A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Adults With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), and/or With Severe Hypertriglyceridemia (NCT05355402) | Ionis Pharmaceuticals, Inc. | 2022-05-09 |
| A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD) (NCT05378529) | Amgen | 2022-04-19 |
| The Belgian REAL (BE.REAL) Registry (NCT05726838) | Novartis Pharmaceuticals | 2022-04-15 |
| Generalizability of REDUCE-IT Results to People of South Asian Descent With Atherosclerotic Cardiovascular Disease in Canada (REDUCE-IT Canada SA) (NCT05271591) | Canadian Medical and Surgical Knowledge Translation Research Group | 2022-03-05 |
| Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease (NCT05030428) | Novartis Pharmaceuticals | 2021-11-23 |
| Non-interventional Study on the Monthly Administration of 300 mg AliRocumab (PRALUENT®) With the 2 ml SYDNEY Auto-injector (NCT05129241) | Sanofi | 2021-11-18 |
| A Research Study Looking at How the Medicine NNC0385-0434 Works in the Body of Healthy Japanese Men (NCT05003440) | Novo Nordisk A/S | 2021-08-19 |
| A Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Cholesterol in People With Heart Disease or a High Risk of Heart Disease (NCT04992065) | Novo Nordisk A/S | 2021-08-03 |
| Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support (NCT04807400) | Novartis Pharmaceuticals | 2021-07-07 |
| Impact of Optimal Pharmacotherapy on Lipid Profile and Qualitative Features of Atherosclerotic Plaques (NCT05639218) | Pauls Stradins Clinical University Hospital | 2021-06-29 |
| A Randomized Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTORION-INITIATE) (NCT04929249) | Novartis Pharmaceuticals | 2021-06-25 |
| Recipe for Heart Health (NCT04828447) | University of Florida | 2021-04-14 |
| Incidental Coronary Calcification Quality Improvement Project (NCT04789278) | Stanford University | 2021-03-30 |
| Effects of Ezetimibe Combination Therapy for Patients With Atherosclerotic Cardiovascular Disease; Randomized Comparison of LDL-cholesterol Targeting <70 Versus <55mg/dL; Ez-PAVE Trial (NCT04626973) | Yonsei University | 2021-01-15 |
| Impact of PCSK9 Inhibitors on Coronary Microvascular Dysfunction in Patients With Atherosclerotic Cardiovascular Disease Proved by Myocardial Ischemia and Needing Coronarography (NCT04338165) | University Hospital, Grenoble | 2021-01-08 |
| Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis (NCT04271735) | National Heart, Lung, and Blood Institute (NHLBI) | 2020-08-26 |
| Compressive Elastic Dressing Versus TR Band (NCT05409716) | An-Najah National University | 2020-08-01 |
| The Young Heart Study (NCT04462159) | Northwell Health | 2020-05-27 |
| Changes of Muramyl Dipeptide in Intestinal and Extra-intestinal Diseases (NCT04924686) | Zhujiang Hospital | 2020-05-10 |
| Association Between Dietary Habits and Risk Factors for Atherosclerotic Cardiovascular Diseases in Assiut Governorate (NCT03505073) | Assiut University | 2020-05-01 |
| Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events (NCT04271280) | Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | 2020-03-17 |
| Behavioral Economic Approaches to Increase Physical Activity Among Patients With Elevated Risk for Cardiovascular Disease (NCT03911141) | University of Pennsylvania | 2019-04-12 |
| Effect of Evolocumab on Vascular Function (NCT03626831) | University of Erlangen-Nürnberg Medical School | 2019-04-04 |
| Evaluation of the Novel Use of Gamification With Alternative Goal-setting Experiences (NCT03749473) | University of Pennsylvania | 2019-01-14 |
| A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease (NCT03705234) | University of Oxford | 2018-10-30 |
| Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DM (NCT03597412) | Yuhan Corporation | 2018-10-17 |
| The Learning Registry (NCT03911284) | Duke University | 2018-09-01 |
| High-intensity Rosuvastatin vs. Moderate-intensity Rosuvastatin/Ezetimibe in High Atherosclerotic Cardiovascular Disease Risk Patients With Type 2 Diabetes (NCT03403556) | Yuhan Corporation | 2018-03-27 |
| How Atorvastatin Affects the Gut Flora and Metabolomics? (NCT04215237) | First Affiliated Hospital Xi'an Jiaotong University | 2017-11-13 |
| Impact of Evolocumab on the Effects of Clopidogrel in Patients With High On-Treatment Platelet Reactivity (NCT03096288) | University of Florida | 2017-10-03 |
| Subclinical Cardiovascular Disease in Psoriatic Disease (NCT03228017) | NYU Langone Health | 2017-08-01 |
| An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol (NCT03060577) | Novartis Pharmaceuticals | 2017-04-27 |
| Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE) (NCT03067441) | Esperion Therapeutics, Inc. | 2017-02-03 |
| The Effect of Anacetrapib on Vascular Function and Arterial Stiffness (NCT02931188) | Cambridge University Hospitals NHS Foundation Trust | 2017-01-01 |
| Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk (NCT02991118) | Esperion Therapeutics, Inc. | 2016-11-18 |
| Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant (NCT02988115) | Esperion Therapeutics, Inc. | 2016-11-16 |
| Proof of Mechanism Study of MLN1202 on Atherosclerotic Inflammation in Participants With Stable Atherosclerotic Cardiovascular Disease (NCT02388971) | Takeda | 2016-04-01 |
| Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term (NCT02697916) | Duke University | 2016-04-01 |
| Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C) (NCT02597127) | The Medicines Company | 2016-01-01 |
| Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study (NCT02576067) | Icahn School of Medicine at Mount Sinai | 2015-12-18 |
| Proof of Concept Study of BMS-823778 to Assess the Effects on Atherosclerosis (NCT01666704) | Bristol-Myers Squibb | 2014-04-01 |
| Assessment of the Role of the Growth Hormone (GH) Onthe Intestinal Triglyceride-rich-lipoproteins (TRL) Metabolism (NCT01572259) | Assistance Publique Hopitaux De Marseille | 2011-09-01 |
| REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification (NCT01252953) | University of Oxford | 2011-06-01 |
| Short-term Changes on C-Reactive Protein (CRP) Levels After Non-surgical Periodontal Treatment (NCT01433744) | State University of Maringá | 2010-01-01 |
| Heme Oxygenase (HO) Activity and Adenosine Induced Vasodilation (NCT00856817) | Radboud University Medical Center | 2009-03-01 |
| Olmesartan Medoxomil in Atherosclerosis (NCT00185185) | Sankyo Pharma Gmbh | 2001-11-01 |
| Multicenter Trial of Meditation and Health Education for Cardiometabolic Disease in Black Women (NCT06443814) | Robert Schneider, MD | 2001-07-01 |
| Gastric Bypass Versus Best Medical Treatment on Progression of Carotid-intima Media Thickness in Type 2 Diabetes Mellitus (T2DM) (NCT01353066) | Hospital Clinic of Barcelona | |